TABLE OF CONTENT 1 EXECUTIVE SUMMARY 2 MARKET INTRODUCTION 2.1 SCOPE OF THE STUDY 14 2.2 RESEARCH OBJECTIVE 14 2.3 MARKET STRUCTURE 14 2.4 ASSUMPTIONS & LIMITATIONS 15 3 RESEARCH METHODOLOGY 3.1 DATA MINING 16 3.2 SECONDARY RESEARCH 17 3.3 PRIMARY RESEARCH 18 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 19 3.5 FORECASTING TECHNIQUES 19 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 20 3.6.1 BOTTOM-UP APPROACH 21 3.6.2 TOP-DOWN APPROACH 21 3.7 DATA TRIANGULATION 22 3.8 VALIDATION 22 4 MARKET DYNAMICS 4.1 OVERVIEW 23 4.2 DRIVERS 24 4.2.1 GROWING RATE OF INFERTILITY IN THE WORLD 24 4.2.2 CHANGING LIFESTYLE AMONG POPULATION 24 4.2.3 RISE IN NHS FUNDED IN FERTILITY MARKET 24 4.3 RESTRAINTS 25 4.3.1 HIGH RISK OF CONCEIVING TWINS OR TRIPLETS AND OTHER COMPLICATIONS SUCH AS PREMATURE BIRTH OR MISCARRIAGE 25 4.4 OPPORTUNITIES 26 4.4.1 MEDICAL INSURANCE FOR THE COUPLES OF SAME SEXES 26 5 MARKET FACTOR ANALYSIS 5.1 VALUE CHAIN ANALYSIS 27 5.1.1 CONSULTING DOCTOR FOR EVALUATION 27 5.1.2 FERTILITY TESTING OF MALE & FEMALE 28 5.1.3 DIAGNOSIS 28 5.1.4 INSEMNINATION OF SPERM 28 5.2 PORTER’S FIVE FORCES MODEL 29 5.2.1 BARGAINING POWER OF SUPPLIERS 29 5.2.2 BARGAINING POWER OF BUYERS 29 5.2.3 THREAT OF NEW ENTRANTS 29 5.2.4 THREAT OF SUBSTITUTES 30 5.2.5 RIVALRY 30 5.3 COVID-19 IMPACT ANALYSIS 30 5.3.1 IMPACT ON GROWTH RATE 30 5.3.2 IMPACT ON MAJOR PLAYERS 30 5.3.3 IMPACT ON MAJOR REGIONS 30 6 GLOBAL ARTIFICIAL INSEMINATION MARKET, BY TYPE 6.1 OVERVIEW 32 6.2 INTRAUTERINE 33 6.3 INTRACERVICAL 33 6.4 INTRATUBAL 34 7 GLOBAL ARTIFICIAL INSEMINATION MARKET, BY END USER 7.1 OVERVIEW 35 7.2 HOSPITALS & CLINICS 36 7.3 FERTILITY CENTRE 36 7.4 HOME-BASED 37 8 GLOBAL ARTIFICIAL INSEMINATION MARKET, BY REGION 8.1 OVERVIEW 38 8.2 AMERICAS 39 8.2.1 NORTH AMERICA 40 8.2.1.1 US 41 8.2.1.2 CANADA 42 8.2.2 LATIN AMERICA 43 8.3 EUROPE 44 8.3.1 WESTERN EUROPE 45 8.3.1.1 GERMANY 47 8.3.1.2 FRANCE 47 8.3.1.3 UK 48 8.3.1.4 ITALY 49 8.3.1.5 SPAIN 49 8.3.1.6 BELGIUM 50 8.3.1.7 SWEDEN 51 8.3.1.8 DENMARK 51 8.3.1.9 FINLAND 52 8.3.1.10 NORWAY 53 8.3.1.11 REST OF WESTERN EUROPE 53 8.3.2 EASTERN EUROPE 54 8.4 ASIA-PACIFIC 55 8.4.1 JAPAN 56 8.4.2 CHINA 57 8.4.3 INDIA 58 8.4.4 AUSTRALIA 58 8.4.5 SOUTH KOREA 59 8.4.6 REST OF ASIA-PACIFIC 60 8.5 MIDDLE EAST & AFRICA 61 8.5.1 MIDDLE EAST 62 8.5.2 AFRICA 63 9 COMPETITIVE LANDSCAPE 9.1 OVERVIEW 64 9.2 COMPETITIVE BENCHMARKING 65 9.3 COMPETITOR DASHBOARD 66 9.4 MAJOR GROWTH STRATEGY IN THE GLOBAL ARTIFICIAL INSEMINATION MARKET 67 9.5 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ARTIFICIAL INSEMINATION MARKET 67 9.6 KEY DEVELOPMENT ANALYSIS 68 9.7 KEY DEVELOPMENTS & GROWTH STRATEGIES 68 9.7.1 PARTNERSHIPS/COLLABORATIONS/AGREEMENTS 68 9.7.2 EXPANSIONS 68 10 COMPANY PROFILES 10.1 VITROLIFE AB 69 10.1.1 COMPANY OVERVIEW 69 10.1.2 FINANCIAL OVERVIEW 70 10.1.3 PRODUCTS/SERVICES OFFERED 71 10.1.4 KEY DEVELOPMENTS 71 10.1.5 SWOT ANALYSIS 72 10.1.6 KEY STRATEGIES 72 10.2 GENEA LIMITED 73 10.2.1 COMPANY OVERVIEW 73 10.2.2 FINANCIAL OVERVIEW 73 10.2.3 PRODUCTS/SERVICES OFFERED 73 10.2.4 KEY DEVELOPMENTS 73 10.2.5 SWOT ANALYSIS 74 10.2.6 KEY STRATEGIES 74 10.3 RINOVUM WOMEN’S HEALTH, LLC 75 10.3.1 COMPANY OVERVIEW 75 10.3.2 FINANCIAL OVERVIEW 75 10.3.3 PRODUCTS/SERVICES OFFERED 75 10.3.4 KEY DEVELOPMENTS 75 10.3.5 SWOT ANALYSIS 76 10.3.6 KEY STRATEGIES 76 10.4 PRIDE ANGEL 77 10.4.1 COMPANY OVERVIEW 77 10.4.2 FINANCIAL OVERVIEW 77 10.4.3 PRODUCTS/SERVICES OFFERED 77 10.4.4 KEY DEVELOPMENTS 77 10.4.5 SWOT ANALYSIS 78 10.4.6 KEY STRATEGIES 78 10.5 HI-TECH SOLUTIONS 79 10.5.1 COMPANY OVERVIEW 79 10.5.2 FINANCIAL OVERVIEW 79 10.5.3 PRODUCTS/SERVICES OFFERED 79 10.5.4 KEY DEVELOPMENTS 79 10.5.5 SWOT ANALYSIS 80 10.5.6 KEY STRATEGIES 80 10.6 KITAZATO CORPORATION 81 10.6.1 COMPANY OVERVIEW 81 10.6.2 FINANCIAL OVERVIEW 81 10.6.3 PRODUCTS/SERVICES OFFERED 81 10.6.4 KEY DEVELOPMENTS 82 10.6.5 SWOT ANALYSIS 82 10.6.6 KEY STRATEGIES 82 10.7 FUJIFILM IRVINE SCIENTIFIC, INC. 83 10.7.1 COMPANY OVERVIEW 83 10.7.2 FINANCIAL OVERVIEW 83 10.7.3 PRODUCTS/SERVICES OFFERED 84 10.7.4 KEY DEVELOPMENTS 84 10.7.5 SWOT ANALYSIS 84 10.7.6 KEY STRATEGIES 85 10.8 ROCKET MEDICAL 86 10.8.1 COMPANY OVERVIEW 86 10.8.2 FINANCIAL OVERVIEW 86 10.8.3 PRODUCTS/SERVICES OFFERED 87 10.8.4 KEY DEVELOPMENTS 87 10.8.5 SWOT ANALYSIS 87 10.8.6 KEY STRATEGIES 87 11 APPENDIX 11.1 REFERENCES 88 11.2 RELATED REPORTS 89

LIST OF TABLES TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 15 TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 18 TABLE 3 GLOBAL ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 32 TABLE 4 GLOBAL ARTIFICIAL INSEMINATION MARKET, FOR INTRAUTERINE, BY REGION, 2017-2027 (USD MILLION) 33 TABLE 5 GLOBAL ARTIFICIAL INSEMINATION MARKET, FOR INTRACERVICAL, BY REGION, 2017-2027 (USD MILLION) 34 TABLE 6 GLOBAL ARTIFICIAL INSEMINATION MARKET, FOR INTRATUBAL, BY REGION, 2017-2027 (USD MILLION) 34 TABLE 7 GLOBAL ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 35 TABLE 8 GLOBAL ARTIFICIAL INSEMINATION MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2017-2027 (USD MILLION) 36 TABLE 9 GLOBAL ARTIFICIAL INSEMINATION MARKET, FOR FERTILITY CENTRE, BY REGION, 2017-2027 (USD MILLION) 36 TABLE 10 GLOBAL ARTIFICIAL INSEMINATION MARKET, FOR HOME-BASED, BY REGION, 2017-2027 (USD MILLION) 37 TABLE 11 GLOBAL ARTIFICIAL INSEMINATION MARKET, BY REGION, 2017-2027 (USD MILLION) 38 TABLE 12 AMERICAS: ARTIFICIAL INSEMINATION MARKET, BY REGION, 2017-2027 (USD MILLION) 39 TABLE 13 AMERICAS: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 40 TABLE 14 AMERICAS: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 40 TABLE 15 NORTH AMERICA: ARTIFICIAL INSEMINATION MARKET, BY COUNTRY, 2017-2027 (USD MILLION) 41 TABLE 16 NORTH AMERICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 41 TABLE 17 NORTH AMERICA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 41 TABLE 18 US: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 41 TABLE 19 US: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 42 TABLE 20 CANADA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 42 TABLE 21 CANADA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 42 TABLE 22 LATIN AMERICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 43 TABLE 23 LATIN AMERICA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 43 TABLE 24 EUROPE: ARTIFICIAL INSEMINATION MARKET, BY REGION, 2017-2027 (USD MILLION) 44 TABLE 25 EUROPE: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 45 TABLE 26 EUROPE: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 45 TABLE 27 WESTERN EUROPE: ARTIFICIAL INSEMINATION MARKET, BY COUNTRY, 2017-2027 (USD MILLION) 46 TABLE 28 WESTERN EUROPE: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 46 TABLE 29 WESTERN EUROPE: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 46 TABLE 30 GERMANY: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 47 TABLE 31 GERMANY: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 47 TABLE 32 FRANCE: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 47 TABLE 33 FRANCE: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 48 TABLE 34 UK: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 48 TABLE 35 UK: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 48 TABLE 36 ITALY: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 49 TABLE 37 ITALY: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 49 TABLE 38 SPAIN: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 49 TABLE 39 SPAIN: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 50 TABLE 40 BELGIUM: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 50 TABLE 41 BELGIUM: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 50 TABLE 42 SWEDEN: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 51 TABLE 43 SWEDEN: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 51 TABLE 44 DENMARK: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 51 TABLE 45 DENMARK: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 52 TABLE 46 FINLAND: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 52 TABLE 47 FINLAND: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 52 TABLE 48 NORWAY: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 53 TABLE 49 NORWAY: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 53 TABLE 50 REST OF WESTERN EUROPE: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 53 TABLE 51 REST OF WESTERN EUROPE: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 54 TABLE 52 EASTERN EUROPE: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 54 TABLE 53 EASTERN EUROPE: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 54 TABLE 54 ASIA-PACIFIC: ARTIFICIAL INSEMINATION MARKET, BY COUNTRY, 2017-2027 (USD MILLION) 55 TABLE 55 ASIA-PACIFIC: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 56 TABLE 56 ASIA-PACIFIC: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 56 TABLE 57 JAPAN: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 56 TABLE 58 JAPAN: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 57 TABLE 59 CHINA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 57 TABLE 60 CHINA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 57 TABLE 61 INDIA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 58 TABLE 62 INDIA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 58 TABLE 63 AUSTRALIA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 58 TABLE 64 AUSTRALIA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 59 TABLE 65 SOUTH KOREA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 59 TABLE 66 SOUTH KOREA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 59 TABLE 67 REST OF ASIA-PACIFIC: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 60 TABLE 68 REST OF ASIA-PACIFIC: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 60 TABLE 69 MIDDLE EAST & AFRICA: ARTIFICIAL INSEMINATION MARKET, BY COUNTRY, 2017-2027 (USD MILLION) 61 TABLE 70 MIDDLE EAST & AFRICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 62 TABLE 71 MIDDLE EAST & AFRICA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 62 TABLE 72 MIDDLE EAST: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 62 TABLE 73 MIDDLE EAST: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 63 TABLE 74 AFRICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2017-2027 (USD MILLION) 63 TABLE 75 AFRICA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2017-2027 (USD MILLION) 63 TABLE 76 MAJOR MANUFACTURERS IN THE GLOBAL ARTIFICIAL INSEMINATION MARKET 65 TABLE 77 BENCHMARKING OF MAJOR COMPETITORS 65 TABLE 78 COMPETITOR DASHBOARD: GLOBAL ARTIFICIAL INSEMINATION MARKET 66 TABLE 79 MOST ACTIVE PLAYER IN THE GLOBAL ARTIFICIAL INSEMINATION MARKET 67 TABLE 80 PARTNERSHIPS/COLLABORATIONS/AGREEMENTS 68 TABLE 81 EXPANSIONS 68 TABLE 82 VITROLIFE AB: PRODUCTS/SERVICES OFFERED 71 TABLE 83 VITROLIFE AB: KEY DEVELOPMENTS 71 TABLE 84 GENEA LIMITED: PRODUCTS/SERVICES OFFERED 73 TABLE 85 RINOVUM WOMEN’S HEALTH, LLC: PRODUCTS/SERVICES OFFERED 75 TABLE 86 RINOVUM WOMEN’S HEALTH, LLC: KEY DEVELOPMENTS 75 TABLE 87 PRIDE ANGEL: PRODUCTS/SERVICES OFFERED 77 TABLE 88 HI-TECH SOLUTIONS: PRODUCTS/SERVICES OFFERED 79 TABLE 89 KITAZATO CORPORATION: PRODUCTS/SERVICES OFFERED 81 TABLE 90 KITAZATO CORPORATION: KEY DEVELOPMENTS 82 TABLE 91 FUJIFILM IRVINE SCIENTIFIC, INC.: PRODUCTS/SERVICES OFFERED 84 TABLE 92 ROCKET MEDICAL: PRODUCTS/SERVICES OFFERED 87

Vitrolife AB, Genea Limited, Rinovum Women’s Health, LLC, Pride Angel, Hi-tech Solutions, Kitazato Corporation, Fujifilm Irvine Scientific, and Rocket Medical